Table 3.

Univariate and multivariate analyses of the contribution of FOXS1 on the survival of GC patients.

Clinical parameters	Univariate analysis		Multivariate analysis
	HRa (95%CI)	P value	HRa (95%CI)	P value
FOXS1	1.001 (1.000–1.003)	0.009**	1.002 (1.000–1.003)	0.009**
Age (years)	1.022 (1.004–1.041)	0.017**	1.033 (1.014–1.052)	0.001**
T stage (T1 + T2/T3 + T4)	1.306 (1.038–1.643)	0.023*	1.203 (0.931–1.555)	0.158
N stage (No/Yes)	1.259 (1.013–1.565)	0.038*	1.014 (0.732–1.404)	0.934
M stage (No/Yes)	1.501 (1.153–1.955)	0.003**	1.433 (1.095–1.876)	0.009**
Stage(I + II/III + IV)	1.356 (1.119–1.642)	0.002**	1.254 (0.927–1.696)	0.143
Grade(I + II/III + IV)	1.194 (0.986–1.446)	0.069	—	—
Tumor size(< = 10 mm/>10 mm)	3.182 (1.614–2.671)	<0.001***	—	—
Gender	1.467 (0.978–2.199)	0.064	—	—

^aHR, hazad ratio. ^*P < 0.05, ^**P < 0.01, ^***P < 0.001 were considered statistically significant.